share_log

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target

Cantor Fitzgerald Reiterates Overweight on Health Catalyst, Maintains $16 Price Target

坎托·菲茨杰拉德重申增持健康催化剂,维持16美元的目标股价
Benzinga ·  04/10 10:16

Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Overweight and maintains $16 price target.

坎托·菲茨杰拉德分析师莎拉·詹姆斯重申Health Catalyst(纳斯达克股票代码:HCAT)增持,目标股价维持16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发